您的位置: 首页 > 农业专利 > 详情页

Avelumab Dosage Regimen For Cancer Treatment
专利权人:
MERCK PATENT GMBH;PFIZER INC.
发明人:
CARLO LEONEL BELLO,GLEN IAN ANDREWS,PASCAL GIRARD,SATJIT SINGH BRAR,SHAONAN WANG
申请号:
BR112019006504
公开号:
BR112019006504A2
申请日:
2017.10.05
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
The present invention relates to avelumab dosage regimen for the treatment of cancer. in particular, the invention relates to an improved avelumab dosage regimen for the treatment of cancer.a presente invenção refere-se ao regime de dosagem de avelumabe para o tratamento de câncer. em particular, a invenção refere-se a um regime de dosagem aprimorado do avelumabe para o tratamento de câncer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充